We are live on
!
Find out more
GAA
Green Alpha Advisors Portfolio holdings
AUM
$148M
Turnover
14.17%
1-Year Est. Return
98.22%
This Fund
S&P 500
This Quarter
Est. Return
-14.13%
1 Year Est. Return
+98.22%
3 Year Est. Return
+315.88%
5 Year Est. Return
+340.2%
10 Year Est. Return
–
AUM
$435M
AUM Growth
+$287M
(+194%)
Cap. Flow
+$340M
Cap. Flow
% of AUM
78.01%
Top 10 Holdings %
Top 10 Hldgs %
35.36%
Holding
156
New
20
Increased
102
Reduced
26
Closed
7
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookfield Renewable
BEPC
|
+$18.3M |
| 2 |
TSMC
TSM
|
+$16.4M |
| 3 |
JinkoSolar
JKS
|
+$15.8M |
| 4 |
IBM
IBM
|
+$13.6M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$12.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Omnicell
OMCL
|
+$718K |
| 2 |
Teladoc Health
TDOC
|
+$461K |
| 3 |
Everpure Inc
P
|
+$422K |
| 4 |
Philips
PHG
|
+$342K |
| 5 |
Iron Mountain
IRM
|
+$327K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 46.84% |
| 2 | Healthcare | 14.05% |
| 3 | Real Estate | 9.06% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Utilities | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
10x Genomics
TXG
$9.43B
| $520K | 0.12% |
11,493
+3,492
| +44% | +$181K |
2021 Q1
5 quarters
|
|
127
OraSure Technologies
OSUR
$263M
| $506K | 0.12% |
+186,563
| New | +$928K |
2022 Q2
0 quarters
|
|
128
Advanced Drainage Systems
WMS
$9.69B
| $498K | 0.11% |
5,527
-612
| -10% | -$62.9K |
2021 Q2
4 quarters
|
|
129
Vertex Pharmaceuticals
VRTX
$129B
| $464K | 0.11% |
1,646
-1,189
| -42% | -$318K |
2021 Q1
5 quarters
|
|
130
Array Technologies
ARRY
$550M
| $457K | 0.1% |
41,502
+2,578
| +7% | +$25.5K |
2021 Q2
4 quarters
|
|
131
Twist Bioscience
TWST
$9.58B
| $455K | 0.1% |
13,001
+5,333
| +70% | +$189K |
2021 Q2
4 quarters
|
|
132
DELISTED
Primo Water Corporation
PRMW
| $437K | 0.1% |
32,682
+1,414
| +5% | +$19.9K |
2021 Q2
4 quarters
|
|
133
BioNTech
BNTX
$22.7B
| $426K | 0.1% |
2,855
-1,151
| -29% | -$176K |
2021 Q2
4 quarters
|
|
134
Protolabs
PRLB
$2.09B
| $387K | 0.09% |
8,080
+140
| +2% | +$6.49K |
2022 Q1
1 quarter
|
|
135
Beam Therapeutics
BEAM
$2.55B
| $378K | 0.09% |
+9,769
| New | +$388K |
2022 Q2
0 quarters
|
|
136
T1 Energy
TE
$878M
| $370K | 0.09% |
+54,046
| New | +$473K |
2022 Q2
0 quarters
|
|
137
Energy Vault
NRGV
$556M
| $360K | 0.08% |
+35,931
| New | +$467K |
2022 Q2
0 quarters
|
|
138
Intuitive Surgical
ISRG
$151B
| $359K | 0.08% |
+1,787
| New | +$419K |
2022 Q2
0 quarters
|
|
139
Personalis
PSNL
$1.7B
| $342K | 0.08% |
99,118
+65,073
| +191% | +$331K |
2021 Q2
4 quarters
|
|
140
Chegg
CHGG
$84.4M
| $336K | 0.08% |
+17,867
| New | +$409K |
2022 Q2
0 quarters
|
|
141
Guardant Health
GH
$22.3B
| $245K | 0.06% |
+6,061
| New | +$300K |
2022 Q2
0 quarters
|
|
142
Inovio Pharmaceuticals
INO
$108M
| $226K | 0.05% |
10,883
+4,284
| +65% | +$121K |
2021 Q2
4 quarters
|
|
143
Power Integrations
POWI
$2.51B
| $216K | 0.05% |
2,880
| – | – |
2020 Q4
6 quarters
|
|
|
NSTG
144
DELISTED
NanoString Technologies, Inc.
NSTG
| $214K | 0.05% |
16,814
+6,076
| +57% | +$113K |
2021 Q2
4 quarters
|
|
145
DELISTED
Exact Sciences
EXAS
| $212K | 0.05% |
5,383
+307
| +6% | +$16.4K |
2021 Q1
5 quarters
|
|
146
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $212K | 0.05% |
249
+179
| +256% | +$315K |
2022 Q1
1 quarter
|
|
|
ATHX
147
DELISTED
Athersys, Inc. Common Stock
ATHX
| $191K | 0.04% |
29,339
+20,519
| +233% | +$227K |
2021 Q2
4 quarters
|
|
148
DELISTED
CureVac
CVAC
| $167K | 0.04% |
+12,247
| New | +$203K |
2022 Q2
0 quarters
|
|
149
DELISTED
2seventy bio
TSVT
| $165K | 0.04% |
+12,509
| New | +$170K |
2022 Q2
0 quarters
|
|
150
DELISTED
bluebird bio
BLUE
| – | – |
-733
| Closed | -$71K | – |
|
Similar funds
BM
LFWA
RLWM
ACM
BSTWA
NI
TWPM
AA
Green Alpha Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Green Alpha Advisors held 156 positions worth $435M, up 194% from $148M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Green Alpha Advisors deployed $340M of net new capital in Q2 2022, opening 20 new positions and adding to 102 existing holdings. Its largest new stake was GSK: 61,436 shares worth $3.34M.
By sector, the portfolio is most concentrated in Technology at 47% of assets, down from 50% a quarter earlier, followed by Healthcare and Real Estate.
On the sell side, the largest reduction was Everpure Inc, an estimated $422K trimmed.
- Green Alpha Advisors's largest Q2 2022 buy was GSK: 61,436 shares worth $3.34M.
- Green Alpha Advisors added most to Brookfield Renewable in Q2 2022, an estimated $18.3M increase.
- Green Alpha Advisors's biggest Q2 2022 reduction was Everpure Inc, cutting an estimated $422K.
- Green Alpha Advisors fully exited Omnicell in Q2 2022, selling an estimated $718K.
- Green Alpha Advisors's ten largest holdings make up 35% of its $435M portfolio in Q2 2022.
- Green Alpha Advisors opened 20 new positions and closed 7 in Q2 2022.
- Green Alpha Advisors's portfolio value rose 194% quarter-over-quarter to $435M.
Based on Green Alpha Advisors's 13F filing for Q2 2022, filed 8 Jul 2022.